Christopher P Kiritsy insider trades

Open-market stock purchases and sales by Christopher P Kiritsy, Director at Palvella Therapeutics, Inc, from SEC Form 4 filings since Sep 20, 2016.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +166%.

Recent trades

DateStockTradeValue
Sep 2, 2026PVLA Palvella Therapeutics, IncBought (not open market)$39.8K
Sep 2, 2026PVLA Palvella Therapeutics, IncSold$49.1K
Sep 2, 2026PVLA Palvella Therapeutics, IncBought (not open market)—
Jun 10, 2026PVLA Palvella Therapeutics, IncBought (not open market)—

Companies traded

  • PVLA Palvella Therapeutics, Inc: 1 sale, last Sep 2, 2026
  • PIRS Pieris Pharmaceuticals, Inc: 2 buys, last Dec 2, 2024
  • HTGM HTG Molecular Diagnostics, Inc: other filings, last Sep 15, 2022

Get free alerts when Christopher P Kiritsy files a new trade →